Latest News for: prostate

Edit

Charities call for prostate cancer ruling to be overturned after review finds decision to deny ...

The Daily Mail 24 Feb 2026
The UK National Screening Committee issued draft guidance in November saying the routine checks should only be offered in very limited circumstances ....
Edit

Prostate cancer tumors have more than twice as much of this pollutant as healthy tissue: study

New York Post 24 Feb 2026
Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer, the most common cancer among American men ... The prevalence of prostate cancer is only ...
Edit

Vir Biotechnology Reports Positive Updated Phase 1 Results for PSMA-targeting, PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 in Patients with Metastatic Prostate Cancer

Pharmiweb 24 Feb 2026
Dose‑dependent activity was observed across the entire treatment group as measured by both prostate-specific antigen (PSA) declines and radiographic responses ... About Advanced Prostate Cancer ... “Prostate cancer statistics, 2025.” CA Cancer J Clin.
Edit

Thousands of men with prostate cancer are being denied 'a quality of life-preserving' treatment by ...

The Daily Mail 23 Feb 2026
Focal therapy, a non-invasive treatment which targets cancerous cells while avoiding damaging surrounding tissue, was introduced to the UK in 2006. ....
Edit

Allies are worried about the toll prostate cancer is taking on former president Biden: report

The Independent 23 Feb 2026
Close friends and allies say he appears more fatigued behind closed doors .
Edit

Everyday plastic exposure could increase prostate cancer risk, scientists warn -�as cases climb

The Daily Mail 23 Feb 2026
While experts stress the findings are early and do not prove cause and effect, they add to growing concern about how widespread plastic exposure may affect the body over time ....
Edit

Microplastics found in prostate tumors in small study

NBC News 23 Feb 2026
In a new study, researchers found microplastics deep inside prostate cancer tumors, raising more questions about the role the ubiquitous pollutants play in public health ... .
Edit

A landmark “evolutionary double-bind” strategy to overcome treatment resistance in prostate cancer (Trinity College Dublin - The University of Dublin)

Public Technologies 23 Feb 2026
) A landmark "evolutionary double-bind" strategy to overcome treatment resistance in prostate cancer Posted on ... [...]. This is an abstract of the document ... Disclaimer.
Edit

Prostate cancer screening programme rejection ‘based on old facts’

The Daily Telegraph 23 Feb 2026
A prostate cancer committee has been accused of exaggerating the risks of screening ... Prostate Cancer, Prostate Cancer Testing Saves Lives, Wes Streeting, NHS (National Health Service), Cancer.
Edit

New prostate cancer treatment offered at Texas Oncology in Longview ‘works like a charm’

Longview News-Journal 23 Feb 2026
Taylor, right, and his patient Tyson Johnson talk about a treatment recently made available to prostate cancer patients during an interview Wednesday, February 11, 2026, at Texas Oncology-Longview Cancer Center.
Edit

Prostate cancer breakthrough at TCD

RTE 23 Feb 2026
A new study led by Trinity College Dublin (TCD) shows how radiation therapy can be used to expose, and then eliminate, therapy-resistant prostate cancer cells using the body's natural killer cells.
Edit

We have a blood test to detect prostate cancer, so why the reluctance to screen?

The Irish Times 23 Feb 2026
There have been renewed calls for the introduction of a national screening programme for prostate cancer in the UK ... Prostate cancer is the most common cancer in men if skin cancer is excluded ... [ Prostate cancer.
Edit

Microplastics Discovered in Prostate Tumors

PR Newswire 23 Feb 2026
23, 2026 /PRNewswire/ -- Small fragments of plastic were found in nine out of 10 patients with prostate cancer, and in higher levels inside tumors than in nearby noncancerous tissue, a new study finds.
Edit

Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer

PR Newswire 23 Feb 2026
VIR) today announced they have entered into a global strategic collaboration to advance VIR-5500, an investigational PRO-XTEN® dual-masked CD3 T-cell engager (TCE) targeting PSMA for the treatment of prostate cancer.
Edit

Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer (Form 8-K) (Vir Biotechnology Inc)

Public Technologies 23 Feb 2026
) Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer ... prostate cancer.

Article Search

tools
×
×
×
×